Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,540 signal articles · 30 in last 24h · 122,378 total before filter · latest 1h ago
30last 24h
1247last 7d
209● bullish (7d)
149● bearish (7d)
205publishers
AllMacro210Earnings428M&A97Regulatory24Product9Analyst10
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
5 Must-Read Analyst Questions From RBC Bearings’s Q1 Earnings Call
StockStory92d agoneutral
5 Must-Read Analyst Questions From RBC Bearings’s Q1 Earnings Call

RBC Bearings delivered first quarter results that surpassed Wall Street’s revenue and non-GAAP profit expectations, but the market responded negatively. Management credited robust demand in its aerospace and defense (A&D) business, particularly from the marine, missile, and space sectors, as primary drivers behind the revenue growth. CEO Michael Hartnett highlighted, “Our A&D business has continued to deliver exceptional performance with segment revenue increasing 41.2% compared to the prior yea

NXP Semiconductors (NXPI) Is Up 8.6% After Strong Q1 Beat and Upbeat Guidance - What's Changed
Simply Wall St.92d agobullish
NXP Semiconductors (NXPI) Is Up 8.6% After Strong Q1 Beat and Upbeat Guidance - What's Changed

NXP Semiconductors recently reported Q1 revenue and earnings that exceeded expectations, aided by strength in automotive, industrial, and IoT segments, while advancing initiatives like the CoreRide Z248 electric-vehicle system and strategic manufacturing investments. This combination of operational outperformance, confident Q2 guidance, and expanding partnerships has sharpened investor focus on how NXP’s core end-markets and technology roadmap may influence its longer-term business...

CRISPR Therapeutics AG (CRSP) Reports Q1 2026 Results
Insider Monkey92d agoneutral
CRISPR Therapeutics AG (CRSP) Reports Q1 2026 Results

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the 10 Best ARK Stocks to Buy Right Now. On May 4, CRISPR Therapeutics AG (NASDAQ:CRSP) reported its first quarter 2026 results and advanced its pipeline and commercial launch. The company reported a net loss of $122.9 million for Q1 2026, lower than $136.0 million a year earlier. […]

Lululemon (LULU): Buy, Sell, or Hold Post Q4 Earnings?
StockStory92d agoneutral
Lululemon (LULU): Buy, Sell, or Hold Post Q4 Earnings?

Lululemon’s stock price has taken a beating over the past six months, shedding 25.9% of its value and falling to $124.61 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

Strong Retail Earnings in a Tough Environment
Zacks92d agoneutral
Strong Retail Earnings in a Tough Environment

Strong results from Walmart's general merchandise business is a key takeaway from its results. The very strong sales performance at Target confirms this favorable reading, suggesting that the persistent softness in discretionary spending categories in the post-COVID period may have run its course.

BofA makes blunt call on Target stock price after guidance
TheStreet92d agoneutral
BofA makes blunt call on Target stock price after guidance

Target gave investors a better profit outlook after its latest quarter, yet Bank of America is still taking a cautious view on the stock as the retailer works through a longer turnaround in a competitive consumer backdrop. BofA reiterated its Underperform rating on Target and kept its $110 price ...

DraftKings (DKNG) Reports Q1 2026 Revenue of $1.65B, Up 17% YoY
Insider Monkey92d agoneutral
DraftKings (DKNG) Reports Q1 2026 Revenue of $1.65B, Up 17% YoY

DraftKings Inc. (NASDAQ:DKNG) is one of the best low priced growth stocks to invest in now. On May 7, DraftKings reported Q1 2026 revenue of $1.646 billion, up 17% from $1.409 billion in Q1 2025. This increase was driven by efficient customer acquisition, strong consumer engagement, and an improved Sportsbook net revenue margin. The company […]

Southern Copper (SCCO) Valuation Check After Earnings Beats And Cuajone Mine Expansion Plan
Simply Wall St.92d agobullish
Southern Copper (SCCO) Valuation Check After Earnings Beats And Cuajone Mine Expansion Plan

Why Southern Copper Stock Is Back in Focus Southern Copper (SCCO) is back on investors radar after a stronger earnings outlook, continued quarterly earnings beats and a new US$318.6 million upgrade plan for its Cuajone mine in Peru. See our latest analysis for Southern Copper. The US$179.12 share price has eased in recent months, with the 90 day share price return down 10%, even as the year to date share price return sits at 22.7% and the 1 year total shareholder return is 110.7%. This hints...

Intuit earnings put Morgan Stanley stock forecast to the test
TheStreet92d agoneutral
Intuit earnings put Morgan Stanley stock forecast to the test

Intuit’s latest earnings report gave investors fresh evidence for the bull case Morgan Stanley laid out before the company’s fiscal third-quarter results, while also leaving some of Wall Street’s biggest concerns around TurboTax and artificial intelligence unresolved. The company reported fiscal ...